# RASGRP2

## Overview
RASGRP2 is a gene that encodes the protein RAS guanyl releasing protein 2, also known as CalDAG-GEFI, which functions as a guanine nucleotide exchange factor (GEF). This protein is integral to cellular signal transduction, primarily through its role in activating small GTPases such as Rap1. RAS guanyl releasing protein 2 is involved in various physiological processes, including platelet aggregation, immune cell function, and endothelial cell survival, by facilitating the 'inside-out' activation of integrins and modulating signaling pathways that prevent apoptosis and regulate vascular permeability (Canault2020RasGRP2; Takino2019The). The protein is characterized by its multidomain structure, which includes a CDC-25 homology domain, Ras exchanger motif (REM) domain, EF-hand domains, and a C1 domain, each contributing to its regulatory functions (Czikora2016Structural; Canault2020RasGRP2). Mutations in the RASGRP2 gene are associated with platelet-type bleeding disorder-18 (BDPLT18), highlighting its clinical significance in hemostasis (Canault2020RasGRP2; PalmaBarqueros2019RASGRP2).

## Structure
RASGRP2 is a multidomain protein that plays a crucial role in signal transduction. It contains a central catalytic module composed of the CDC-25 homology domain and the Ras exchanger motif (REM) domain, which facilitate interaction with GTPases and support catalytic activity (Canault2020RasGRP2). The protein also includes EF-hand domains that bind calcium, leading to conformational changes, and a C1 domain, which binds diacylglycerol (DAG) with weak affinity (Czikora2016Structural; Canault2020RasGRP2). The C1 domain of RasGRP2 is atypical compared to other RasGRP family members, showing very weak binding affinity to phorbol esters due to specific amino acid residues (Czikora2016Structural).

RasGRP2 undergoes post-translational modifications, including phosphorylation by protein kinase A (PKA) and ERK1/2, which regulate its activity by inhibiting Rap1 activation and impairing nucleotide exchange activity, respectively (Canault2020RasGRP2). The protein is encoded by the RASGRP2 gene located on chromosome 11 and is expressed in various cell types, including platelets and megakaryocytes (Canault2020RasGRP2). The canonical isoform of RasGRP2 is 609 amino acids long and has several characterized phosphorylation sites (Canault2020RasGRP2).

## Function
RASGRP2, also known as CalDAG-GEFI, is a guanine nucleotide exchange factor (GEF) that plays a significant role in activating small GTPases, particularly Rap1, in healthy human cells. This activation is crucial for various cellular processes, including platelet aggregation, immune cell function, and endothelial cell survival (Canault2020RasGRP2; Takino2019The). In platelets, RASGRP2 is involved in the 'inside-out' activation of αIIbβ3 integrin, which is essential for platelet aggregation and normal hemostasis (Canault2020RasGRP2).

In endothelial cells, RASGRP2 contributes to maintaining cellular homeostasis by preventing apoptosis and reducing reactive oxygen species (ROS) production. It achieves this by activating the R-Ras-PI3K-Akt signaling pathway, which inhibits Bax translocation to mitochondria, thereby suppressing apoptosis (Sato2019RASGRP2; Takino2019The). RASGRP2 also plays a role in vascular permeability regulation by activating Rap1, which suppresses vascular hyperpermeability through the NOX-ROS pathway (Takino2021The).

The protein is primarily active in the cytoplasm and at the plasma membrane, where it influences signal transduction pathways that affect cellular proliferation, differentiation, and adhesion (Canault2020RasGRP2).

## Clinical Significance
Mutations in the RASGRP2 gene are linked to a bleeding disorder known as platelet-type bleeding disorder-18 (BDPLT18), characterized by moderate to severe mucocutaneous bleeding. This condition is caused by impaired platelet function due to defective activation of the αIIbβ3 integrin, which is crucial for platelet aggregation and adhesion (Canault2020RasGRP2; PalmaBarqueros2019RASGRP2). Patients with BDPLT18 often experience symptoms such as epistaxis, menorrhagia, and bleeding following surgical procedures (Canault2020RasGRP2).

The RASGRP2 gene encodes CalDAG-GEFI, a protein essential for integrin-mediated platelet aggregation. Mutations in this gene, including missense and frameshift variants, lead to a lack of functional CalDAG-GEFI, resulting in impaired platelet aggregation and severe bleeding diathesis (Sevivas2017Identification; Rosenberg2021Mutations). These mutations are often misdiagnosed as Glanzmann thrombasthenia due to similar clinical presentations, but can be distinguished through genetic analysis (Rosenberg2021Mutations).

In some cases, heterozygous carriers of RASGRP2 mutations also exhibit mild bleeding symptoms, suggesting a possible autosomal dominant inheritance pattern with variable expressivity (Morais2021CalDAGGEFI). The condition is diagnosed through sequencing of the RASGRP2 gene, which helps differentiate it from other platelet function disorders (Canault2020RasGRP2).

## Interactions
RASGRP2, also known as CalDAG-GEFI, is a guanine nucleotide exchange factor that primarily activates the small GTPase RAP1. It interacts with several proteins and nucleic acids in various cellular contexts. In human T cells, RASGRP2 enhances adhesion through lymphocyte function-associated antigen-1 (LFA1) and contributes to interactions with intercellular adhesion molecule-1 (ICAM-1). It translocates to the cell membrane via interaction with polymerized actin in response to TCR stimulation, where it co-localizes with its substrate, Rap1 (Canault2020RasGRP2).

In endothelial cells, RASGRP2 overexpression prevents TNF-α-induced ROS production and apoptosis via a Rap1 activation-dependent mechanism and suppresses apoptosis through a Rap1-independent but R-Ras-dependent signaling pathway (Canault2020RasGRP2). It also activates R-Ras, which in turn activates the PI3K-Akt signaling pathway, playing a crucial role in apoptosis suppression (Takino2019The).

RASGRP2 is involved in dopamine-dependent neuronal excitability and reward-related behaviors via Rap1 activation (Canault2020RasGRP2). It is also implicated in platelet function, where it regulates platelet aggregation and thrombus formation through its interaction with Rap1, crucial for the 'inside-out' activation of the αIIbβ3 integrin (Canault2020RasGRP2).


## References


[1. (Morais2021CalDAGGEFI) Sara Morais, Mónica Pereira, Catarina Lau, Ana Gonçalves, Catarina Monteiro, Marta Gonçalves, Jorge Oliveira, Lurdes Moreira, Eugénia Cruz, Rosário Santos, and Margarida Lima. Caldag-gefi deficiency in a family with symptomatic heterozygous and homozygous carriers of a likely pathogenic variant in rasgrp2. International Journal of Molecular Sciences, 22(22):12423, November 2021. URL: http://dx.doi.org/10.3390/ijms222212423, doi:10.3390/ijms222212423. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms222212423)

[2. (Czikora2016Structural) Agnes Czikora, Daniel J. Lundberg, Adelle Abramovitz, Nancy E. Lewin, Noemi Kedei, Megan L. Peach, Xiaoling Zhou, Raymond C. Merritt, Elizabeth A. Craft, Derek C. Braun, and Peter M. Blumberg. Structural basis for the failure of the c1 domain of ras guanine nucleotide releasing protein 2 (rasgrp2) to bind phorbol ester with high affinity. Journal of Biological Chemistry, 291(21):11133–11147, May 2016. URL: http://dx.doi.org/10.1074/jbc.m116.725333, doi:10.1074/jbc.m116.725333. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m116.725333)

[3. (Takino2019The) Jun-ichi Takino, Takuma Sato, Kentaro Nagamine, and Takamitsu Hori. The inhibition of bax activation-induced apoptosis by rasgrp2 via r-ras-pi3k-akt signaling pathway in the endothelial cells. Scientific Reports, November 2019. URL: http://dx.doi.org/10.1038/s41598-019-53419-4, doi:10.1038/s41598-019-53419-4. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-53419-4)

[4. (Sevivas2017Identification) Teresa Sevivas, José María Bastida, David S. Paul, Eva Caparros, Verónica Palma-Barqueros, Margarida Coucelo, Dalila Marques, Francisca Ferrer-Marín, José Ramón González-Porras, Vicente Vicente, Jesús María Hernández-Rivas, Steve P. Watson, María Luisa Lozano, Wolfgang Bergmeier, and José Rivera. Identification of two novel mutations in rasgrp2 affecting platelet caldag-gefi expression and function in patients with bleeding diathesis. Platelets, 29(2):192–195, August 2017. URL: http://dx.doi.org/10.1080/09537104.2017.1336214, doi:10.1080/09537104.2017.1336214. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/09537104.2017.1336214)

[5. (PalmaBarqueros2019RASGRP2) Verónica Palma-Barqueros, Juan Ruiz-Pividal, Natalia Bohdan, Vicente Vicente, Jose Maria Bastida, María Lozano, and José Rivera. Rasgrp2 gene variations associated with platelet dysfunction and bleeding. Platelets, 30(4):535–539, March 2019. URL: http://dx.doi.org/10.1080/09537104.2019.1585528, doi:10.1080/09537104.2019.1585528. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/09537104.2019.1585528)

[6. (Takino2021The) Jun-ichi Takino, Shouhei Miyazaki, Kentaro Nagamine, and Takamitsu Hori. The role of rasgrp2 in vascular endothelial cells—a mini review. International Journal of Molecular Sciences, 22(20):11129, October 2021. URL: http://dx.doi.org/10.3390/ijms222011129, doi:10.3390/ijms222011129. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms222011129)

[7. (Canault2020RasGRP2) Matthias Canault and Marie-Christine Alessi. Rasgrp2 structure, function and genetic variants in platelet pathophysiology. International Journal of Molecular Sciences, 21(3):1075, February 2020. URL: http://dx.doi.org/10.3390/ijms21031075, doi:10.3390/ijms21031075. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21031075)

[8. (Rosenberg2021Mutations) Nurit Rosenberg, Rima Dardik, Hagit Hauschner, Sigal Nakav, Ortal Barel, Jacob Luboshitz, Joanne Yacobovich, Hannah Tamary, and Gili Kenet. Mutations in rasgrp2 gene identified in patients misdiagnosed as glanzmann thrombasthenia patients. Blood Cells, Molecules, and Diseases, 89:102560, July 2021. URL: http://dx.doi.org/10.1016/j.bcmd.2021.102560, doi:10.1016/j.bcmd.2021.102560. This article has 4 citations.](https://doi.org/10.1016/j.bcmd.2021.102560)

[9. (Sato2019RASGRP2) Takuma Sato, Jun-ichi Takino, Kentaro Nagamine, Kazuto Nishio, and Takamitsu Hori. Rasgrp2 suppresses apoptosis via inhibition of ros production in vascular endothelial cells. The Scientific World Journal, 2019:1–8, January 2019. URL: http://dx.doi.org/10.1155/2019/4639165, doi:10.1155/2019/4639165. This article has 15 citations.](https://doi.org/10.1155/2019/4639165)